Back to Search
ALLISON CAPALDI, PHARMD
PHARMD
Pharmacist
NPI: 1780961854Individual
Specialties, Licenses & Credentials
PharmacistPrimary
Pharmacist
Code: 183500000X
28RI03286800(NJ)
Research & Publications (20)
Reduced-intensity allogeneic hematopoietic stem cell transplantation in metastatic colorectal cancer as a novel adoptive cell therapy approach. The European group for blood and marrow transplantation experience.
PMID 19203723·Biol Blood Marrow Transplant·2009
3-trial
Structure and function of a transcriptional network activated by the MAPK Hog1.
PMID 18931682·Nat Genet·2008
8-other
Oral melphalan, prednisone, and thalidomide in elderly patients with multiple myeloma: updated results of a randomized controlled trial.
PMID 18505783·Blood·2008
2-rct
Alloreactivity and anti-tumor activity segregate within two distinct subsets of cytokine-induced killer (CIK) cells: implications for their infusion across major HLA barriers.
PMID 18469328·Int Immunol·2008
8-other
Allogeneic nonmyeloablative hematopoietic cell transplantation in metastatic colon cancer: tumor-specific T cells directed to a tumor-associated antigen are generated in vivo during GVHD.
PMID 16403911·Blood·2006
8-other
Lentiviral transduction of primary myeloma cells with CD80 and CD154 generates antimyeloma effector T cells.
PMID 15871676·Hum Gene Ther·2005
8-other
Trapping the on-pathway folding intermediate of Im7 at equilibrium.
PMID 15312774·J Mol Biol·2004
8-other
Intermediate-dose melphalan improves survival of myeloma patients aged 50 to 70: results of a randomized controlled trial.
PMID 15265788·Blood·2004
3-trial
A phase II study of three-weekly docetaxel and weekly trastuzumab in HER2-overexpressing advanced breast cancer.
PMID 15031597·Oncology·2004
3-trial
Equilibrium hydrogen exchange reveals extensive hydrogen bonded secondary structure in the on-pathway intermediate of Im7.
PMID 15001361·J Mol Biol·2004
8-other
Dose-dense vinorelbine and paclitaxel with granulocyte colony-stimulating factor in metastatic breast cancer patients: anti-tumor activity and peripheral blood progenitor cell mobilization capability.
PMID 14703065·Breast Cancer Res Treat·2003
3-trial
Expression of the c-ErbB-2/HER2 proto-oncogene in normal hematopoietic cells.
PMID 12960261·J Leukoc Biol·2003
8-other
Safety and activity of docetaxel and trastuzumab in HER2 overexpressing metastatic breast cancer: a pilot phase II study.
PMID 12576933·Am J Clin Oncol·2003
3-trial
Structural analysis of the rate-limiting transition states in the folding of Im7 and Im9: similarities and differences in the folding of homologous proteins.
PMID 12547210·J Mol Biol·2003
4-observational
Im7 folding mechanism: misfolding on a path to the native state.
PMID 11875516·Nat Struct Biol·2002
8-other
Acidic conditions stabilise intermediates populated during the folding of Im7 and Im9.
PMID 11575937·J Mol Biol·2001
8-other
A DNA polymerase beta mutator mutant with reduced nucleotide discrimination and increased protein stability.
PMID 11560485·Biochemistry·2001
4-observational
Detection of breast cancer cell contamination in leukapheresis product by real-time quantitative polymerase chain reaction.
PMID 11313686·Bone Marrow Transplant·2001
4-observational
Using chimeric immunity proteins to explore the energy landscape for alpha-helical protein folding.
PMID 11243827·J Mol Biol·2001
8-other
Ultrarapid mixing experiments reveal that Im7 folds via an on-pathway intermediate.
PMID 11135674·Nat Struct Biol·2001
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1401 ATLANTIC AVE, STE 1000
ATLANTIC CITY, NJ 08401 - Phone
- (609) 441-7088
Quick Facts
- NPI
- 1780961854
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile